Codex DNA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Codex DNA generated cash of -$38,715,000, which is less than the previous year. Cash used in financing activities reached the amount of $4,510,000 last year. Net change in cash is therefore -$52,212,000.
Cash Flow
| 2020 | -15.38M | -204K | -96K |
|---|---|---|---|
| 2021 | -36.69M | -15.04M | 121.08M |
| 2022 | -38.71M | -18.00M | 4.51M |
DNAY Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 82.80M | 13.46M | 29.14M |
Operating activities | |||
Net income | -48.47M | -38.95M | -18.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 1.67M | 908K | 1.45M |
Stock-based compensation expense | 3.72M | 1.08M | 43K |
| Deferred income tax benefit | 3.72M | 1.08M | 43K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -2.18M | -735K | -774K |
Inventories | 168K | -1.46M | 111K |
Accounts payable | 1.16M | 4.39M | 142K |
Cash generated by operating activities | -38.71M | -36.69M | -15.38M |
Investing activities | |||
Purchases Of Investments | -77.42M | 0 | 0 |
Investments In Property Plant And Equipment | -4.46M | -1.85M | -204K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -18.00M | -15.04M | -204K |
Financing activities | |||
Common Stock Issued | 98K | 112.48M | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -107K |
Cash used in financing activities | 4.51M | 121.08M | -96K |
Net Change In Cash | -52.21M | 69.34M | -15.68M |
Cash at end of period | 30.59M | 82.80M | 13.46M |
| Data source | Data source |